NPs Basic Information

Name
Menthyl acetate
Molecular Formula C12H22O2
IUPAC Name*
(5-methyl-2-propan-2-ylcyclohexyl) acetate
SMILES
CC1CCC(C(C1)OC(=O)C)C(C)C
InChI
InChI=1S/C12H22O2/c1-8(2)11-6-5-9(3)7-12(11)14-10(4)13/h8-9,11-12H,5-7H2,1-4H3
InChIKey
XHXUANMFYXWVNG-UHFFFAOYSA-N
Synonyms
Menthyl acetate; 16409-45-3; Menthol, acetate; 89-48-5; Menthyl acetate racemic; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate; 29066-34-0; (5-methyl-2-propan-2-ylcyclohexyl) acetate; 2623-23-6; (+/-)-Menthyl acetate; 2230-87-7; 2-Isopropyl-5-methylcyclohexyl acetate; (+)-Neomenthyl acetate; d-Neomenthyl acetate; L-Menthyl acetate;(-)-Menthyl acetate; 5-Methyl-2-(1-methylethyl)cyclohexanol acetate; Neomenthol acetate; FEMA Number 2668; HSDB 824; (.+/-.)-Menthol acetate; EINECS 240-459-6; Acetic acid, p-menth-3-yl ester, dl-; AI3-36197; Menthanyl acetate; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate, (1R,2R,5R)-rel-; Menthol, neo-; CYCLOHEXANOL, 5-METHYL-2-(1-METHYLETHYL)-, ACETATE, (1.ALPHA.,2.BETA.,5.ALPHA.)-; 20777-36-0; EINECS 218-767-7; (5R)-2-Isopropyl-5-methylcyclohexyl acetate; starbld0011430; Menthyl acetate, 97%; MENTHYLACETATE97; (2-isopropyl-5-methyl-cyclohexyl) acetate; acetic acid menthyl ester; SCHEMBL57396; CHEMBL254585; 2-Isopropyl-5-methylcyclohexyl acetate, (1.alpha.,2.beta.,5.alpha.)-; DTXSID20859153; NSC7350; Acetic acid, p-menth-3-yl ester; CHEBI:191550; (1S)-(+)-MENTHYLACETATE; NSC-7350; DL-Menthyl acetate, >=97%, FG; NSC122112; AKOS015837885; cis-1,3,trans-1,4- menthol acetate; NSC 122112; NSC-122112; SB44841; SB46743; AS-83629; DB-063670; DB-071375; FT-0604526; FT-0604554; FT-0628207; FT-0631427; FT-0690234; FT-0694110; W-100373; Cyclohexanol, acetate, (1.alpha.,2.alpha.,5.beta.)-; Menthyl acetate, primary pharmaceutical reference standard; Cyclohexanol, acetate, [1S-(1.alpha.,2.alpha.,5.beta.)]-; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate, (1alpha,2alpha,5beta)-; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate, (1.alpha.,2.beta.,5.alpha.)-(.+/-.)-
CAS 16409-45-3
PubChem CID 27867
ChEMBL ID CHEMBL254585
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Monoterpenoids
          • Direct Parent: Menthane monoterpenoids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Loading...
Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Showing 0 to 0 of 0 entries

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity NameTarget IDTarget NameTarget TypeTarget OrganismTarget Organism IDPotency of BioactivityActivity TypeValueUnitEndophyte IDEndophyte Name
Bioactivity Name
Target ID
Target Name
Target Type
Target Organism
Target Organism ID
Potency of Bioactivity
Activity Type
Value
Unit
Endophyte ID
Endophyte Name
Bioactivity Name
Target ID
Target Name
Target Type
Target Organism
Target Organism ID
Potency of Bioactivity
Activity Type
Value
Unit
Endophyte ID
Endophyte Name
Loading...
Bioactivity NameTarget IDTarget NameTarget TypeTarget OrganismTarget Organism IDPotency of BioactivityActivity TypeValueUnitEndophyte IDEndophyte Name
Showing 0 to 0 of 0 entries

NPs Physi-Chem Properties

Molecular Weight: 198.3 ALogp: 3.6
HBD: 0 HBA: 2
Rotatable Bonds: 3 Lipinski's rule of five: Accepted
Polar Surface Area: 26.3 Aromatic Rings: 1
Heavy Atoms: 14 QED Weighted: 0.631

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.441 MDCK Permeability: 0.00002240
Pgp-inhibitor: 0.003 Pgp-substrate: 0.002
Human Intestinal Absorption (HIA): 0.004 20% Bioavailability (F20%): 0.07
30% Bioavailability (F30%): 0.625

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.81 Plasma Protein Binding (PPB): 87.27%
Volume Distribution (VD): 1.037 Fu: 10.30%

ADMET: Metabolism

CYP1A2-inhibitor: 0.117 CYP1A2-substrate: 0.121
CYP2C19-inhibitor: 0.028 CYP2C19-substrate: 0.919
CYP2C9-inhibitor: 0.139 CYP2C9-substrate: 0.718
CYP2D6-inhibitor: 0.006 CYP2D6-substrate: 0.15
CYP3A4-inhibitor: 0.13 CYP3A4-substrate: 0.395

ADMET: Excretion

Clearance (CL): 6.67 Half-life (T1/2): 0.318

ADMET: Toxicity

hERG Blockers: 0.012 Human Hepatotoxicity (H-HT): 0.25
Drug-inuced Liver Injury (DILI): 0.78 AMES Toxicity: 0.023
Rat Oral Acute Toxicity: 0.015 Maximum Recommended Daily Dose: 0.022
Skin Sensitization: 0.697 Carcinogencity: 0.193
Eye Corrosion: 0.571 Eye Irritation: 0.893
Respiratory Toxicity: 0.078
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

*Note: the compound similarity was calculated by RDKIT.